RALOXIFENE - ORAL
Common Brand Name(s): Evista
Phonetic Pronunciation: (ra-LOX-ih-feen)
Information last revised June 2010
What does RALOXIFENE ORAL look like?
Evista 60 mg Tab
Raloxifene is used to prevent and treat bone loss (osteoporosis) in women after menopause. Maintaining strong bones by slowing bone loss helps to reduce the risk of fractures. Raloxifene may also lower the chance of getting a certain type of breast cancer (invasive) in women after menopause. This drug is different from hormones (including estrogens and progestins). It works by acting like estrogen (as a selective estrogen receptor modulator or SERM) in some parts of the body. Raloxifene helps to preserve bone mass, but it does not affect the breast and uterus like estrogen or relieve symptoms of menopause such as hot flashes. This medication is not recommended for use in women before menopause. It should not be used in children. This medication should not be used to prevent heart disease.
This is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate for you. This information is not individual medical advice and does not substitute for the advice of your health care professional. Always ask your health care professional for complete information about this product and your specific health needs.
The information contained in the First DataBank databases is intended to supplement the knowledge of physicians, pharmacists, and other healthcare professionals regarding drug therapy problems and patient counselling information. This information is advisory only and is not intended to replace sound clinical judgment in the delivery of healthcare services. First DataBank disclaims all warranties, whether expressed or implied, including any warranty as to the quality, accuracy, and suitability of this information for any purpose.
Copyright 2010 First DataBank, Inc.